First Time Loading...

bluebird bio Inc
NASDAQ:BLUE

Watchlist Manager
bluebird bio Inc Logo
bluebird bio Inc
NASDAQ:BLUE
Watchlist
Price: 0.9742 USD -0.96%
Updated: May 23, 2024

bluebird bio Inc
Short-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

bluebird bio Inc
Short-Term Investments Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Short-Term Investments Analysis
Latest Figures & CAGR of Competitors

Company Short-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
bluebird bio Inc
NASDAQ:BLUE
Short-Term Investments
$8.9m
CAGR 3-Years
-79%
CAGR 5-Years
-59%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Short-Term Investments
$2m
CAGR 3-Years
-55%
CAGR 5-Years
-64%
CAGR 10-Years
-46%
Gilead Sciences Inc
NASDAQ:GILD
Short-Term Investments
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Short-Term Investments
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Short-Term Investments
$1B
CAGR 3-Years
18%
CAGR 5-Years
12%
CAGR 10-Years
1%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Short-Term Investments
$7.9B
CAGR 3-Years
56%
CAGR 5-Years
39%
CAGR 10-Years
46%

See Also

What is bluebird bio Inc's Short-Term Investments?
Short-Term Investments
8.9m USD

Based on the financial report for Sep 30, 2023, bluebird bio Inc's Short-Term Investments amounts to 8.9m USD.

What is bluebird bio Inc's Short-Term Investments growth rate?
Short-Term Investments CAGR 5Y
-59%

Over the last year, the Short-Term Investments growth was -88%. The average annual Short-Term Investments growth rates for bluebird bio Inc have been -79% over the past three years , -59% over the past five years .